158 related articles for article (PubMed ID: 12622625)
21. Improved prediction of the minimal phototoxic dose in PUVA therapy.
Sakuntabhai A; Matthews JN; Farr PM
Br J Dermatol; 1994 May; 130(5):604-9. PubMed ID: 8204468
[TBL] [Abstract][Full Text] [Related]
22. [Consensus document on bath-PUVA therapy. The Spanish Photobiology Group of the Spanish Academy of Dermatology and Venereology].
Rodríguez-Granados MT; Carrascosa JM; Gárate T; Gómez-Díez S; Guimaraens-Juantorena D
Actas Dermosifiliogr; 2007 Apr; 98(3):164-70. PubMed ID: 17504700
[TBL] [Abstract][Full Text] [Related]
23. Assessment of minimal phototoxic dose following 8-methoxypsoralen bath: maximal reaction on average after 5 days.
Behrens-Williams S; Gruss C; Grundmann-Kollmann M; Peter RU; Kerscher M
Br J Dermatol; 2000 Jan; 142(1):112-5. PubMed ID: 10651704
[TBL] [Abstract][Full Text] [Related]
24. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
Sakuntabhai A; Farr PM; Diffey BL
Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
[TBL] [Abstract][Full Text] [Related]
25. Response of psoriasis to twice weekly PUVA.
Sakuntabhai A; Sharpe GR; Farr PM
Br J Dermatol; 1993 Feb; 128(2):166-71. PubMed ID: 8457450
[TBL] [Abstract][Full Text] [Related]
26. Psoralen-ultraviolet A-induced erythema: sensitivity correlates with the concentrations of psoralen in suction blister fluid.
Yeo UC; Shin JH; Yang JM; Park KB; Kim MM; Bok HS; Lee ES
Br J Dermatol; 2000 Apr; 142(4):733-9. PubMed ID: 10792224
[TBL] [Abstract][Full Text] [Related]
27. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
Calzavara-Pinton P
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
[TBL] [Abstract][Full Text] [Related]
28. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
Koulu LM; Jansén CT
J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of PUVA bath phototoxicity.
Neumann NJ; Kerscher M; Ruzicka T; Lehmann P
Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
[TBL] [Abstract][Full Text] [Related]
30. PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study.
Schiener R; Gottlöber P; Müller B; Williams S; Pillekamp H; Peter RU; Kerscher M
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):62-7. PubMed ID: 15752122
[TBL] [Abstract][Full Text] [Related]
31. Time course of 8-methoxypsoralen-induced skin photosensitization in PUVA-bath photochemotherapy.
Reuther T; Gruss C; Behrens S; von Kobyletzki G; Neumann N; Lehmann P; Altmeyer P; Kerscher M
Photodermatol Photoimmunol Photomed; 1997; 13(5-6):193-6. PubMed ID: 9542757
[TBL] [Abstract][Full Text] [Related]
32. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis.
Markham T; Rogers S; Collins P
Arch Dermatol; 2003 Mar; 139(3):325-8. PubMed ID: 12622624
[TBL] [Abstract][Full Text] [Related]
33. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis.
Hofer A; Fink-Puches R; Kerl H; Quehenberger F; Wolf P
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):1-5. PubMed ID: 16436174
[TBL] [Abstract][Full Text] [Related]
34. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.
Dayal S; ; Jain VK
Indian J Dermatol Venereol Leprol; 2010; 76(5):533-7. PubMed ID: 20826993
[TBL] [Abstract][Full Text] [Related]
35. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous phototoxicity due to psoralens.
Gange RW; Parrish JA
Natl Cancer Inst Monogr; 1984 Dec; 66():117-26. PubMed ID: 6531018
[TBL] [Abstract][Full Text] [Related]
37. Topical methoxsalen followed immediately by long-wave UV irradiation. A preliminary report on the treatment of psoriasis.
Danno K; Toda K; Ishida H; Horio T
Arch Dermatol; 1982 Jul; 118(7):471-3. PubMed ID: 7092270
[TBL] [Abstract][Full Text] [Related]
38. Effects of water temperature on photosensitization in bath-PUVA therapy with 8-methoxypsoralen.
Gruss C; Behrens S; von Kobyletzki G; Reuther T; Husebo L; Altmeyer P; Kerscher M
Photodermatol Photoimmunol Photomed; 1998; 14(5-6):145-7. PubMed ID: 9826883
[TBL] [Abstract][Full Text] [Related]
39. Cream psoralen plus ultraviolet A therapy for granuloma annulare.
Grundmann-Kollmann M; Ochsendorf FR; Zollner TM; Tegeder I; Kaufmann R; Podda M
Br J Dermatol; 2001 May; 144(5):996-9. PubMed ID: 11359387
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
